Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) Gross Margin (2024 - 2025)

Onconetix (ONCO) has disclosed Gross Margin for 1 consecutive years, with 265.74% as the latest value for Q4 2024.

  • On a quarterly basis, Gross Margin changed N/A to 265.74% in Q4 2024 year-over-year; TTM through Dec 2024 was 67.47%, a N/A change, with the full-year FY2024 number at 120.8%, up 180713.0% from a year prior.
  • Gross Margin was 265.74% for Q4 2024 at Onconetix, down from 25.91% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 26.98% in Q1 2024 to a low of 265.74% in Q4 2024.